Home — MRC Weatherall Institute of Molecular Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Creative image of embryonic stem cells

© Adobe Stock

Study reveals blood stem cells can ‘remember’ inflammation

Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers

Read more

Banner image featuring the words a leader in translating research from bench to clinic, next to an image of a scientist pipetting a pink liquid.

Translating Our Research

Leading research with the aim of improving human health. World-leading research from scientists at the MRC WIMM has been developed into commercial ventures to translate our discoveries into clinics and benefit patients.

Read more

Academy of Medical Sciences elects Professor Tao Dong as new Fellow

Congratulations to Tao Dong, who has been elected a Fellow of the Academy of Medical Sciences in recognition of her outstanding contributions to advancing medical science through discovery research, translational studies, and the application of scientific knowledge for patient and public benefit.

Read more

Research at the MRC WIMM spans 5 core areas.

© Canva, Science Photo Library

MRC WIMM Research Areas

Research at the MRC WIMM spans 5 core areas.

Read more

Researcher hanlding patient samples in a lab.

© Adobe Stock

Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.

Read more

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Discover. Translate. Advance.

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Read more

MRC Translational Immune Discovery Unit

Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.

Find out more

MRC Molecular Haematology Unit

Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.

Find out more

Centre for Computational Biology

Using computational biology to help understand complex biological systems and combat a range of human diseases.

Find out more

Latest publications

TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate

Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111

Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.

Webster RG. et al, (2026), Proc Natl Acad Sci U S A, 123

Nucleophagy removes cytotoxic trapped PARP1.

Hoslett G. et al, (2026), Nat Cell Biol

The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.

Ling RE. et al, (2026), Blood

Human haematopoietic stem cells remember inflammatory stress.

Zeng AGX. et al, (2026), Nature

More Publications

Upcoming Seminars

Gene Transfer and Genome Editing of T cells for Cancer Immunotherapy

Thursday, 04 June 2026, 12pm to 1pm

Speaker(s): Professor Chiara Bonini

Series: WIMM THURSDAY SEMINARS

Status: Cancelled

Gene regulatory mechanisms of non-coding autoimmune risk loci in primary B cells

Friday, 05 June 2026, 9.15am to 10.15am

Speaker(s): Dr Hamish King

Series: TIDU seminars

Targeting leukemia stem cells

Tuesday, 09 June 2026, 1pm to 2pm

Speaker(s): Prof Claudia Lengerke

Series: Molecular Haematology Unit, WIMM

T cell recognition of cancer: ‘Cracking the Code’

Thursday, 11 June 2026, 12pm to 2pm

Speaker(s): Professor Ton Schumacher (Netherlands Cancer Institute)

Series: WIMM THURSDAY SEMINARS

More Seminars

MRC WIMM Interactive Timeline

Accessible Version of Timeline